Has Timothy Benke received payments from drug or device companies?

Yes. Drug and device makers reported $8,610 in general payments to Timothy Benke across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Timothy Benke did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Timothy Benke come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Timothy Benke

Neurology with Special Qualifications in Child Neurology · Aurora, CONPI 1356426092

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,500 of the $8,610 with a category attached, or 75.5%. Acadia Pharmaceuticals Inc accounts for 95.6% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $3,431 and has fallen 62.0% since, to $1,303 in 2025. Among neurology with special qualifications in child neurology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,610in general payments, 2019–2025

Across 15 payments — averaging $574.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Acadia Pharmaceuticals Inc$8K
Sanofi$304
Greenwich Biosciences, Inc.$72

$890,875in research payments, 2019–2025

Across 97 payments — averaging $9184.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Acadia Pharmaceuticals Inc$573K
Ionis Pharmaceuticals, Inc.$157K
Mallinckrodt Enterprises LLC$100K
GW Research Limited$51K
Mallinckrodt Hospital Products Inc.$10K

What the payments were for

Consulting fees$6,50075%
Speaking & faculty fees$1,20014%
Travel & lodging$5166%
Food & beverage$3945%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Acadia Pharmaceuticals Inc	12	$8,234
Sanofi	2	$304
Greenwich Biosciences, Inc.	1	$72

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,610 in reported general payments places this provider in the 90th percentile of 41 neurology with special qualifications in child neurology providers in Colorado.

See all neurology with special qualifications in child neurology providers in Colorado →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lacosamide	18	$10,922
Clobazam	12	$3,605

Paid to pharmacies, not to this prescriber.

Other neurology with special qualifications in child neurology in Aurora

Julie ParsonsAurora$178K
Michele YangAurora$15K
Ryan KammeyerAurora$4K
Teri SchreinerAurora$3K
Marcy YonkerAurora$3K
Jessica LitwinAurora$2K
Jennifer ArmstrongAurora$2K
Abigail CollinsAurora$2K
Jennifer JaskiewiczAurora$937
Benjamin RossAurora$803

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →